EFFECTS OF CHANGES IN CONDITIONING REGIMEN AND SUPPORTIVE CARE ON OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT)

被引:0
|
作者
Abello, V [1 ]
Rosales, C. [1 ]
Pedraza, E. [1 ]
Linares, A. [1 ]
Esguerra, H. [1 ]
Rosales, M. [1 ]
Figueroa, J. [1 ]
机构
[1] Clin Marly, Bogota, Colombia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
200
引用
收藏
页码:S232 / S232
页数:1
相关论文
共 50 条
  • [41] Activity and Tolerability of Azacitidine in Patients Who Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplasia (MDS): a Survey from the European Society for Blood and Marrow Transplantation (EBMT
    Craddock, Charles
    Labopin, Myriam
    Houhou, Mohamed
    Robin, Marie
    Finke, Juergen
    Chevallier, Patrice
    Yakoub-Agha, Ibrahim
    Bourhis, Jean-Henri
    Sengelov, Henrik
    Blaise, Didier
    Dreger, Peter
    Hallek, Michael
    Nagler, Arnon
    Kroger, N.
    Mohty, Mohamad
    BLOOD, 2014, 124 (21)
  • [42] Lymphoid chimerism (LC) kinetic after reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT).
    Mohty, M
    Avinens, O
    Faucher, C
    Furst, S
    Blaise, D
    Eliaou, JF
    BLOOD, 2005, 106 (11) : 1023A - 1024A
  • [43] G to C Transition At Position-173 of MIF Gene Associates with Poor Survival in Acute Myeloid Leukemia Patients and After Allogeneic Stem Cell Transplantation (Allo-SCT)
    Romero, Damia
    Martin-Antonio, Beatriz
    Pratcorona, Marta
    Trujillo, Pablo
    Espigado, Ildefonso
    Gallardo, David
    Bosch, Anna
    Buno, Ismael
    Martinez-Laperche, Carolina
    Jimenz-Velasco, Antonio
    De La Camara, Rafael
    Brunet, Salut
    Nieto, Jose B.
    Roman, Jose
    Suarez-LLedo, Maria
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Rovira, Montserrat
    Esteve, Jordi
    Urbano-Ispizua, Alvaro
    BLOOD, 2011, 118 (21) : 1085 - 1085
  • [44] Impact of Chronic Graft-Versus-Host disease (GVHD) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) As Treatment for Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of the EBMT
    Baron, Frederic
    Labopin, Myriam
    Niederwieser, Dietger
    Milpied, Noel-Jean
    Cornelissen, Jan J.
    Malm, Claes
    Vindelov, Lars
    Blaise, Didier
    Janssen, Jeroen J. W. M.
    Petersen, Eefke J.
    Socie, Gerard
    Rocha, Vanderson
    Nagler, Arnon
    Mohty, Mohamad
    BLOOD, 2011, 118 (21) : 150 - 150
  • [45] The 'cytokine storm' at the era of reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT)
    Mohty, M
    Blaise, D
    Faucher, C
    Vey, N
    Stoppa, AM
    Coso, D
    Viens, P
    Gastaut, JA
    Olive, D
    Gaugler, B
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 84 - 84
  • [46] Chemotherapy followed by donor lymphocyte infusions (DLI) for treatment of acute leukemia recurrence after allogeneic stem cell transplantation (allo-SCT).
    Taylor, K
    Finiewicz, KJ
    Moreb, JS
    Reddy, V
    Khan, SA
    Boyette, R
    Shroff, S
    Roque, D
    Manion, K
    Wingard, JR
    BLOOD, 2000, 96 (11) : 350B - 350B
  • [47] Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT
    Chevallier, Patrice
    Labopin, Myriam
    Buchholz, Stefanie
    Ganser, Arnold
    Ciceri, Fabio
    Lioure, Bruno
    Faul, Chistoph
    Guillerm, Gaelle
    Finke, Juergen
    Anne Huynh
    Schubert, Joerg
    Kolb, Hans-Jochem
    Polge, Emmanuelle
    Nagler, Arnon
    Mohty, Mohamad
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (03) : 214 - 219
  • [48] Late effects in children after allogenic stem cell transplantation (Allo-SCT)
    Llamas Poyato, M. J.
    Molina Hurtado, J. R.
    Chic Acevedo, C.
    Garcia Torres, E.
    Rodriguez Garcia, G.
    Martin Calvo, C.
    Rodriguez Villa, A.
    Rojas Contreras, R.
    Martinez Guibelarde, F.
    Herrera Arroyo, C.
    Gomez Garcia, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S256 - S257
  • [49] Fludarabine-busulphan reduced intensity conditioning (RIC) identical sibling allogeneic stem cell transplantation (Allo-SCT) in high risk acute myeloid leukemia and myelodisplastic syndrome
    Valcarcel, D.
    Martino, R.
    Martin, J.
    Ferra, C.
    Sampol, A.
    Nieto, J. B.
    Carrera, D.
    Pinana, J. L.
    Caballero, D.
    Ribera, J. M.
    Besalduch, J.
    Moraleda, J. M.
    Bernal, M. T.
    San Miguel, J.
    Sierra, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 134 - 135
  • [50] Impact of Cytogenetics Risk on Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) from An HLA Identical Sibling for Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)
    Mohty, Mohamad
    Labopin, Myriam
    Milpied, Noel-Jean
    Cornelissen, Jan J.
    Blaise, Didier
    Petersen, Eefke
    Theorin, Niklas
    Goker, Hakan
    Socie, Gerard
    Rocha, Vanderson
    BLOOD, 2008, 112 (11) : 134 - 135